The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer

[1]  E. Lengyel,et al.  Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.

[2]  Karen R Fitzgerald.  Review of article: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7). , 2013, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[3]  P. Hainaut,et al.  Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose‐response meta‐analysis , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  J. Suttles,et al.  Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner. , 2013, Biochimica et biophysica acta.

[5]  Y. Ozisik,et al.  Association between common risk factors and molecular subtypes in breast cancer patients. , 2013, Breast.

[6]  S. Seok,et al.  Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model , 2013, PloS one.

[7]  N. Rifai,et al.  Adipocytokines, Inflammation, and Breast Cancer Risk in Postmenopausal Women: A Prospective Study , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[8]  M. Chatterjee,et al.  Overexpression of 5‐lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12‐dimethylbenz(α)anthracene‐induced rat mammary carcinogenesis , 2013, Molecular carcinogenesis.

[9]  Jack A. Taylor,et al.  Association between Urinary Prostaglandin E2 Metabolite and Breast Cancer Risk: A Prospective, Case–Cohort Study of Postmenopausal Women , 2013, Cancer Prevention Research.

[10]  C. Hudis,et al.  Increased Levels of Urinary PGE-M, a Biomarker of Inflammation, Occur in Association with Obesity, Aging, and Lung Metastases in Patients with Breast Cancer , 2013, Cancer Prevention Research.

[11]  R. Greil,et al.  Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial , 2013, British Journal of Cancer.

[12]  Yurii B. Shvetsov,et al.  Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer , 2013, Cancer Prevention Research.

[13]  P. Sismondi,et al.  Body mass index (BMI) and breast cancer: impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  A. Jukkola-Vuorinen,et al.  Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype , 2013, Breast Cancer Research and Treatment.

[15]  P. Boyle,et al.  Serum insulin and C-peptide concentration and breast cancer: a meta-analysis , 2013, Cancer Causes & Control.

[16]  A. Tutt,et al.  Differences in breast cancer hormone receptor status in ethnic groups: a London population. , 2013, European journal of cancer.

[17]  E. Salazar,et al.  Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells , 2013, Cellular Oncology.

[18]  T. Hagemann,et al.  Cancer-Related Inflammation , 2012, Journal of Clinical Immunology.

[19]  P. Porter,et al.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population , 2012, Cancer Causes & Control.

[20]  D. Rose,et al.  The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. , 2012, Endocrine-related cancer.

[21]  E. Perez,et al.  Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer , 2012, Cancer.

[22]  G. Hortobagyi,et al.  Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. , 2012, Clinical breast cancer.

[23]  J. Nesland,et al.  Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact. , 2012, Histology and histopathology.

[24]  B. Antuna-Puente,et al.  Adiponectin: anti-inflammatory and cardioprotective effects. , 2012, Biochimie.

[25]  D. Generali,et al.  Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.

[26]  J. Freudenheim,et al.  Adipokines in Plasma and Breast Tissues: Associations with Breast Cancer Risk Factors , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[27]  Christopher I. Li,et al.  Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women , 2012, Breast Cancer Research and Treatment.

[28]  H. Kitagawa,et al.  Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum , 2012, Oncology reports.

[29]  C. Ingvar,et al.  Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort , 2012, Cancer Causes & Control.

[30]  C. Perou,et al.  Dietary Energy Balance Modulates Epithelial-to-Mesenchymal Transition and Tumor Progression in Murine Claudin-Low and Basal-like Mammary Tumor Models , 2012, Cancer Prevention Research.

[31]  P. Goodwin,et al.  Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis , 2012, Breast Cancer Research and Treatment.

[32]  C. Hudis,et al.  Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. , 2012, Cancer discovery.

[33]  A. Verma,et al.  Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition , 2012, Cancer Microenvironment.

[34]  D. Cavazos,et al.  Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells , 2012, Prostate Cancer and Prostatic Diseases.

[35]  J. Frasor,et al.  Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. , 2012, Molecular endocrinology.

[36]  S. Bulun,et al.  Aromatase, breast cancer and obesity: a complex interaction , 2012, Trends in Endocrinology & Metabolism.

[37]  K. Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[38]  W. Han,et al.  COX2 overexpression is a prognostic marker for Stage III breast cancer , 2012, Breast Cancer Research and Treatment.

[39]  M. Fujita,et al.  Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects , 2011, PloS one.

[40]  S. Vernon,et al.  A review of body size and breast cancer risk in Hispanic and African American women , 2011, Cancer.

[41]  Y. Daaka,et al.  PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway. , 2011, Blood.

[42]  C. Madeddu,et al.  Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications , 2011, TheScientificWorldJournal.

[43]  M. Goran,et al.  Subcutaneous Adipose Tissue Macrophage Infiltration Is Associated With Hepatic and Visceral Fat Deposition, Hyperinsulinemia, and Stimulation of NF-κB Stress Pathway , 2011, Diabetes.

[44]  H. Seno,et al.  COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. , 2011, Carcinogenesis.

[45]  Kyoko Kushiro,et al.  Ob/ob serum promotes a mesenchymal cell phenotype in B16BL6 melanoma cells , 2011, Clinical and Experimental Metastasis.

[46]  Changsun Choi,et al.  Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells , 2011, BMC Cancer.

[47]  F. Sarkar,et al.  Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. , 2011, Translational oncology.

[48]  M. Frey,et al.  TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[49]  K. Messer,et al.  Obesity Is an Independent Predictor of Poor Survival in Metastatic Breast Cancer: Retrospective Analysis of a Patient Cohort Whose Treatment Included High-Dose Chemotherapy and Autologous Stem Cell Support , 2011, International journal of breast cancer.

[50]  R. Greil,et al.  Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Wenlian Zhang,et al.  Identification of the Orphan G Protein-coupled Receptor GPR31 as a Receptor for 12-(S)-Hydroxyeicosatetraenoic Acid* , 2011, The Journal of Biological Chemistry.

[52]  C. Hudis,et al.  Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer , 2011, Cancer Prevention Research.

[53]  A. Sudo,et al.  TNF inhibitor suppresses bone metastasis in a breast cancer cell line. , 2011, Biochemical and biophysical research communications.

[54]  Shivendra V. Singh,et al.  Benzyl Isothiocyanate Inhibits Epithelial-Mesenchymal Transition in Cultured and Xenografted Human Breast Cancer Cells , 2011, Cancer Prevention Research.

[55]  Priya Bhardwaj,et al.  Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland , 2011, Cancer Prevention Research.

[56]  M. Karin,et al.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage , 2011, Annals of the rheumatic diseases.

[57]  Jianping Ye.  Adipose Tissue Vascularization: Its Role in Chronic Inflammation , 2011, Current diabetes reports.

[58]  A. Ray,et al.  Obesity and breast cancer: status of leptin and adiponectin in pathological processes , 2010, Cancer and Metastasis Reviews.

[59]  Ayesha Ahmed.  Prognostic and therapeutic role of nuclear factor-kappa B (NF-kappaB) in breast cancer. , 2010, Journal of Ayub Medical College, Abbottabad : JAMC.

[60]  M. Coory,et al.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[61]  L. Castro-Sánchez,et al.  Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A. , 2010, European journal of cell biology.

[62]  J. Fain.  Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review , 2010, Mediators of inflammation.

[63]  J. Clària,et al.  Resolution of Adipose Tissue Inflammation , 2010, TheScientificWorldJournal.

[64]  M. Sjöström,et al.  The Human Visceral Fat Depot Has a Unique Inflammatory Profile , 2010, Obesity.

[65]  D. Rose,et al.  Interaction between menopausal status and obesity in affecting breast cancer risk. , 2010, Maturitas.

[66]  V. Christiaens,et al.  Angiogenesis and development of adipose tissue , 2010, Molecular and Cellular Endocrinology.

[67]  G. Smyth,et al.  Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity , 2010, Diabetes.

[68]  J. Griggs,et al.  Obesity and Angiolymphatic Invasion in Primary Breast Cancer , 2010, Annals of Surgical Oncology.

[69]  M. Karin.  NF-kappaB as a critical link between inflammation and cancer. , 2009, Cold Spring Harbor perspectives in biology.

[70]  J. Inoue,et al.  Constitutive activation of nuclear factor‐κB is preferentially involved in the proliferation of basal‐like subtype breast cancer cell lines , 2009, Cancer science.

[71]  Dali Li,et al.  KiSS1 suppresses TNFα‐induced breast cancer cell invasion via an inhibition of RhoA‐Mediated NF‐κB activation , 2009, Journal of cellular biochemistry.

[72]  D. Rose,et al.  Influence of obesity on breast cancer receptor status and prognosis , 2009, Expert Review of Anticancer Therapy.

[73]  D. Rose,et al.  The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. , 2009, Journal of women's health.

[74]  D. Rose,et al.  Angiogenesis, adipokines and breast cancer. , 2009, Cytokine & growth factor reviews.

[75]  P. Hsieh,et al.  COX‐2‐mediated Inflammation in Fat Is Crucial for Obesity‐linked Insulin Resistance and Fatty Liver , 2009, Obesity.

[76]  B. Evers,et al.  Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. , 2009, Cancer cell.

[77]  D. English,et al.  Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition , 2009, Breast Cancer Research and Treatment.

[78]  T. Stulnig,et al.  Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.

[79]  A. Wolk,et al.  Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—A meta‐analysis , 2009, International journal of cancer.

[80]  G. Hunter,et al.  Insulin Sensitivity in African‐American and White Women: Association With Inflammation , 2009, Obesity.

[81]  G. Hobbs,et al.  Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population , 2008, Cancer Epidemiology Biomarkers & Prevention.

[82]  Jeong Eon Lee,et al.  Berberine Suppresses TNF-α-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells , 2008, Molecules.

[83]  M. Reilly,et al.  Adipose inflammation, insulin resistance, and cardiovascular disease. , 2008, JPEN. Journal of parenteral and enteral nutrition.

[84]  Fritz Schick,et al.  Identification and characterization of metabolically benign obesity in humans. , 2008, Archives of internal medicine.

[85]  W. Jia,et al.  Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. , 2008, American journal of physiology. Endocrinology and metabolism.

[86]  M. Ono.  Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy , 2008, Cancer science.

[87]  A. La Cava,et al.  Leptin and Inflammation. , 2008, Current immunology reviews.

[88]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[89]  A. Tutt,et al.  Triple negative tumours: a critical review , 2007, Histopathology.

[90]  C. Brooks,et al.  Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts. , 2007, Cancer research.

[91]  A. Neugut,et al.  Weight Gain Prior to Diagnosis and Survival from Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[92]  G. Blackburn,et al.  Dietary fat reduction and breast cancer outcome: results from the Women's Intervention Nutrition Study (WINS). , 2007, The American journal of clinical nutrition.

[93]  A. Rosenberg,et al.  Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients , 2007, Cancer.

[94]  S. Bailey,et al.  Nuclear factor-κB activation: a molecular therapeutic target for estrogen receptor–negative and epidermal growth factor receptor family receptor–positive human breast cancer , 2007, Molecular Cancer Therapeutics.

[95]  G. Frühbeck,et al.  Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? , 2007, Current pharmaceutical design.

[96]  D. Rose,et al.  Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. , 2007, Endocrine-related cancer.

[97]  C. Sotiriou,et al.  Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients , 2007, British Journal of Cancer.

[98]  B. Demirkan,et al.  Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma. , 2007, Japanese journal of clinical oncology.

[99]  C. Waes.  Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer , 2007 .

[100]  P. Hall,et al.  Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women , 2006, Cancer Epidemiology Biomarkers & Prevention.

[101]  A. Carmichael,et al.  Obesity and prognosis of breast cancer , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[102]  Xinrong Ma,et al.  Targeting prostaglandin E EP receptors to inhibit metastasis. , 2006, Cancer research.

[103]  R. Coates,et al.  General and Abdominal Obesity and Survival among Young Women with Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[104]  A. Ahmed,et al.  Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy. , 2006, Indian journal of cancer.

[105]  Shailesh Singh,et al.  Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression , 2006, BMC Cancer.

[106]  D. Nie,et al.  Mechanisms Regulating Tumor Angiogenesis by 12-Lipoxygenase in Prostate Cancer Cells* , 2006, Journal of Biological Chemistry.

[107]  F. Clavel-Chapelon,et al.  Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: A study within the EPIC cohort , 2006, International journal of cancer.

[108]  D. Wickerham,et al.  Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer , 2006, Breast Cancer Research and Treatment.

[109]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[110]  B. Aggarwal,et al.  Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals , 2005 .

[111]  Adrian V. Lee,et al.  Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[112]  Jean-Daniel Zucker,et al.  Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. , 2005, Diabetes.

[113]  T. Hagemann,et al.  Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1 , 2005, The Journal of Immunology.

[114]  S. Loi,et al.  Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[115]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[116]  A. Lucci,et al.  COX-2 overexpression increases motility and invasion of breast cancer cells. , 2005 .

[117]  M. Press,et al.  Body weight correlates with mortality in early-stage breast cancer. , 2004, Archives of surgery.

[118]  T. Thorsen,et al.  The associations of obesity, lymph node status and prognosis in breast cancer patients: Dependence on estrogen and progesterone receptor status , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[119]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[120]  A. Madan,et al.  Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.

[121]  B. Uzzan,et al.  Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. , 2004, Cancer research.

[122]  F. Robertson,et al.  Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2. , 2004, Prostaglandins & other lipid mediators.

[123]  G. Hortobagyi,et al.  Prognostic molecular markers in early breast cancer , 2004, Breast Cancer Research.

[124]  P. Westenend,et al.  Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis , 2004, Journal of Clinical Pathology.

[125]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[126]  Steffen Hauptmann,et al.  Prognostic impact of cyclooxygenase-2 in breast cancer. , 2004, Clinical breast cancer.

[127]  R. Shore,et al.  Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study , 2004, British Journal of Cancer.

[128]  S. Sheps,et al.  Waist-to-hip ratio and breast cancer mortality. , 2003, American journal of epidemiology.

[129]  Guoxiong Xu,et al.  Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. , 2003, Experimental cell research.

[130]  M. Cotterchio,et al.  Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[131]  R. Mansel,et al.  Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[132]  A. Howell,et al.  Central obesity and breast cancer risk: a systematic review , 2003, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[133]  W. Weichert,et al.  Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma , 2003, Cancer.

[134]  Ping Zhang,et al.  Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. , 2003, Molecular endocrinology.

[135]  D. Rose,et al.  Breast Cancer and Obesity: An Update , 2003, Nutrition and cancer.

[136]  N. Boyd,et al.  A Meta-Analysis of Published Literature on Waist-to-Hip Ratio and Risk of Breast Cancer , 2002, Nutrition and cancer.

[137]  T. Adrian,et al.  The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. , 2002, Biochemical and biophysical research communications.

[138]  C. Friedenreich,et al.  Case‐control study of anthropometric measures and prostate cancer risk , 2002, International journal of cancer.

[139]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[140]  J. Isola,et al.  Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.

[141]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[142]  S. Davis,et al.  Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives. , 2001, Endocrinology.

[143]  T. Moody,et al.  Five‐lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  P. Porter,et al.  Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma , 2001, Cancer.

[145]  T. Thorsen,et al.  Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status , 2001, Breast Cancer Research and Treatment.

[146]  J. Engelman,et al.  Tumor Necrosis Factor α-Mediated Insulin Resistance, but Not Dedifferentiation, Is Abrogated by MEK1/2 Inhibitors in 3T3-L1 Adipocytes , 2000 .

[147]  D. Rose,et al.  Regulation of Tumor Angiogenesis by Dietary Fatty Acids and Eicosanoids , 2000, Nutrition and cancer.

[148]  L. Bernstein,et al.  Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[149]  D. Nie,et al.  Eicosanoid Regulation of Angiogenesis in Human Prostate Carcinoma and Its Therapeutic Implications , 2000, Annals of the New York Academy of Sciences.

[150]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[151]  B Rosner,et al.  Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. , 1999, American journal of epidemiology.

[152]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[153]  R. Tekmal,et al.  Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands. , 1999, Endocrine-related cancer.

[154]  G. Hotamisligil,et al.  The role of TNF alpha in adipocyte metabolism. , 1999, Seminars in cell & developmental biology.

[155]  D. Rose,et al.  Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. , 1998, Cancer letters.

[156]  S. O’Rahilly,et al.  Tumor Necrosis Factor-α Induces Apoptosis of Human Adipose Cells , 1997, Diabetes.

[157]  S. Wilczynski,et al.  Increased 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor. , 1997, The Journal of clinical endocrinology and metabolism.

[158]  I. Fentiman,et al.  Body weight and vascular invasion in post-menopausal women with breast cancer. , 1997, British Journal of Cancer.

[159]  D. Rose,et al.  The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice. , 1996, Cancer letters.

[160]  I. Adcock,et al.  Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. , 1996, Life sciences.

[161]  C. Mendelson,et al.  Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. , 1996, Molecular endocrinology.

[162]  M. Schrey,et al.  Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin‐1β and phorbol ester: Dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function , 1996, International journal of cancer.

[163]  Xinhua Liu,et al.  Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line , 1996, Clinical & Experimental Metastasis.

[164]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.

[165]  D. Rose,et al.  Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. , 1990, Cancer research.

[166]  G A Colditz,et al.  Weight as a risk factor for clinical diabetes in women. , 1990, American journal of epidemiology.

[167]  R. Elton,et al.  Aromatase activity in adipose tissue from breast quadrants: a link with tumour site , 1988, British medical journal.

[168]  M. Pierobon,et al.  Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis , 2012, Breast Cancer Research and Treatment.

[169]  A. Dobrian,et al.  Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats. , 2011, American journal of physiology. Endocrinology and metabolism.

[170]  S. Bulun,et al.  Regulation of aromatase expression in human tissues , 2004, Breast Cancer Research and Treatment.

[171]  M. Pike,et al.  American Journal of Epidemiology Original Contribution Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status the Multiethnic Cohort Study , 2022 .

[172]  B. Rasmussen,et al.  Bmc Cancer , 2022 .